Sofinnova Venture Partners Vi Gmbh & Co. Kg - Net Worth and Insider Trading

Sofinnova Venture Partners Vi Gmbh & Co. Kg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sofinnova Venture Partners Vi Gmbh & Co. Kg owns 3 companies in total, including Marinus Pharmaceuticals Inc (MRNS) , Ocera Therapeutics Inc (OCRX) , and Anthera Pharmaceuticals Inc (ANTH) .

Click here to see the complete history of Sofinnova Venture Partners Vi Gmbh & Co. Kg’s form 4 insider trades.

Insider Ownership Summary of Sofinnova Venture Partners Vi Gmbh & Co. Kg

Ticker	Company	Transaction Date	Type of Owner
MRNS	Marinus Pharmaceuticals Inc	2016-10-20	10 percent owner
OCRX	Ocera Therapeutics Inc	2014-03-18	10 percent owner
ANTH	Anthera Pharmaceuticals Inc	2011-12-30	10 percent owner

Sofinnova Venture Partners Vi Gmbh & Co. Kg Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sofinnova Venture Partners Vi Gmbh & Co. Kg Ownership Network

Ownership Network List of Sofinnova Venture Partners Vi Gmbh & Co. Kg

No Data

Ownership Network Relation of Sofinnova Venture Partners Vi Gmbh & Co. Kg

Sofinnova Venture Partners Vi Gmbh & Co. Kg Owned Company Details

What does Marinus Pharmaceuticals Inc do?

Who are the key executives at Marinus Pharmaceuticals Inc?

Sofinnova Venture Partners Vi Gmbh & Co. Kg is the 10 percent owner of Marinus Pharmaceuticals Inc. Other key executives at Marinus Pharmaceuticals Inc include Chief Commercial Officer Christina Shafer , CFO Steven Pfanstiel , and Chief Medical Officer Joseph Hulihan .

Marinus Pharmaceuticals Inc (MRNS) Insider Trades Summary

Over the past 18 months, Sofinnova Venture Partners Vi Gmbh & Co. Kg made no insider transaction in Marinus Pharmaceuticals Inc (MRNS). Other recent insider transactions involving Marinus Pharmaceuticals Inc (MRNS) include a net sale of 6,212 shares made by Scott Braunstein , a net sale of 4,828 shares made by Joseph Hulihan , and a net sale of 4,657 shares made by Steven Pfanstiel .

In summary, during the past 3 months, insiders sold 0 shares of Marinus Pharmaceuticals Inc (MRNS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,281 shares of Marinus Pharmaceuticals Inc (MRNS) were sold and 5,933 shares were bought by its insiders, resulting in a net sale of 26,348 shares.

Marinus Pharmaceuticals Inc (MRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marinus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Ocera Therapeutics Inc do?

Who are the key executives at Ocera Therapeutics Inc?

Sofinnova Venture Partners Vi Gmbh & Co. Kg is the 10 percent owner of Ocera Therapeutics Inc. Other key executives at Ocera Therapeutics Inc include 10 percent owner Brian H Dovey , 10 percent owner Domain Partners Viii, L.p. , and 10 percent owner Dp Viii Associates, L.p. .

Ocera Therapeutics Inc (OCRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ocera Therapeutics Inc Insider Transactions

No Available Data

What does Anthera Pharmaceuticals Inc do?

Who are the key executives at Anthera Pharmaceuticals Inc?

Sofinnova Venture Partners Vi Gmbh & Co. Kg is the 10 percent owner of Anthera Pharmaceuticals Inc. Other key executives at Anthera Pharmaceuticals Inc include Chief Medical Officer Shanahan William R Jr , Chief Regulatory Officer Klara Dickinson , and Chief Technology Officer Charles V Olson .

Anthera Pharmaceuticals Inc (ANTH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Anthera Pharmaceuticals Inc (ANTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anthera Pharmaceuticals Inc (ANTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anthera Pharmaceuticals Inc (ANTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Anthera Pharmaceuticals Inc Insider Transactions

No Available Data

Sofinnova Venture Partners Vi Gmbh & Co. Kg Mailing Address

Above is the net worth, insider trading, and ownership report for Sofinnova Venture Partners Vi Gmbh & Co. Kg. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Sofinnova Venture Partners Vi Gmbh & Co. Kg's mailing address is: Menlo Park Ca 94025.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.